Selena Li
About Selena Li
Selena Li is a Senior Research Investigator in Strategic Research Portfolio Management at BeiGene, with extensive experience in vivo pharmacology and a strong academic background in biochemistry.
Current Role at BeiGene
Selena Li currently serves as a Senior Research Investigator in Strategic Research Portfolio Management at BeiGene in Cambridge, Massachusetts. She joined the company in July 2019. Her role involves overseeing and managing strategic research initiatives, contributing to the advancement of BeiGene's oncology pipeline.
Previous Experience at Crown Bioscience, Inc.
Before joining BeiGene, Selena Li worked at Crown Bioscience, Inc. from 2017 to 2019. She held the position of Study Director and Scientist in the In Vivo Pharmacology Group within the China Oncology Scientific Operation. During this time, she gained extensive experience in in vivo pharmacology, with a focus on oncology.
Gap Year Experience
From 2016 to 2017, Selena Li took a gap year dedicated to traveling and preparing for her future career transitions. This year was spent exploring new cultures and gaining a broader understanding of the world, which helped shape her career perspectives and goals.
Educational Background in Biochemistry
Selena Li has a strong academic background in biochemistry. She earned her Doctor of Philosophy in Biochemistry from the University of Kent, where she studied from 2010 to 2016. Prior to that, she received her Bachelor of Science in Biochemistry from the University of Dundee, studying there from 2005 to 2009. She began her academic journey at Beijing Royal School, attending from 2003 to 2005.
Experience in China Oncology Scientific Operation
While at Crown Bioscience, Inc., Selena Li contributed significantly to the China Oncology Scientific Operation. Her work as a Study Director and Scientist involved managing and conducting in vivo pharmacology studies, particularly within the field of oncology. Her efforts in this role have provided a solid foundation for her current position at BeiGene.